Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis

INTRODUCTION: Rheumatoid arthritis (RA) is a chronic systemic auto-immune disease associated with a prothrombotic state. Tocilizumab, an interleukin-6 receptor inhibitor, is highly effective in controlling disease activity and thrombotic risk. Factor XIII (FXIII), involved in thrombotic complication...

Descripción completa

Detalles Bibliográficos
Autores principales: Gualtierotti, Roberta, Ingegnoli, Francesca, Boscolo, Massimo, Griffini, Samantha, Grovetti, Elena, Cugno, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860466/
https://www.ncbi.nlm.nih.gov/pubmed/31654331
http://dx.doi.org/10.1007/s12325-019-01118-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860466/
https://www.ncbi.nlm.nih.gov/pubmed/31654331
http://dx.doi.org/10.1007/s12325-019-01118-x

Ejemplares similares